Literature DB >> 33289207

Antigenic variation of SARS-CoV-2 in response to immune pressure.

Diego Forni1, Rachele Cagliani1, Chiara Pontremoli1, Alessandra Mozzi1, Uberto Pozzoli1, Mario Clerici2,3, Manuela Sironi1.   

Abstract

Analysis of the bat viruses most closely related to SARS-CoV-2 indicated that the virus probably required limited adaptation to spread in humans. Nonetheless, since its introduction in human populations, SARS-CoV-2 must have been subject to the selective pressure imposed by the human immune system. We exploited the availability of a large number of high-quality SARS-CoV-2 genomes, as well as of validated epitope predictions, to show that B cell epitopes in the spike glycoprotein (S) and in the nucleocapsid protein (N) have higher diversity than nonepitope positions. Similar results were obtained for other human coronaviruses and for sarbecoviruses sampled in bats. Conversely, in the SARS-CoV-2 population, epitopes for CD4+ and CD8+ T cells were not more variable than nonepitope positions. A significant reduction in epitope variability was instead observed for some of the most immunogenic proteins (S, N, ORF8 and ORF3a). Analysis over longer evolutionary time frames indicated that this effect is not due to differential constraints. These data indicate that SARS-CoV-2 evolves to elude the host humoral immune response, whereas recognition by T cells is not actively avoided by the virus. However, we also found a trend of lower diversity of T cell epitopes for common cold coronaviruses, indicating that epitope conservation per se is not directly linked to disease severity. We suggest that conservation serves to maintain epitopes that elicit tolerizing T cell responses or induce T cells with regulatory activity.
© 2020 The Authors. Molecular Ecology published by John Wiley & Sons Ltd.

Entities:  

Keywords:  B cell epitope; COVID‐19; SARS‐CoV‐2; T cell epitope; human coronavirus; sarbecovirus

Year:  2020        PMID: 33289207      PMCID: PMC7753431          DOI: 10.1111/mec.15730

Source DB:  PubMed          Journal:  Mol Ecol        ISSN: 0962-1083            Impact factor:   6.622


  79 in total

1.  When t-tests or Wilcoxon-Mann-Whitney tests won't do.

Authors:  Fiona McElduff; Mario Cortina-Borja; Shun-Kai Chan; Angie Wade
Journal:  Adv Physiol Educ       Date:  2010-09       Impact factor: 2.288

2.  Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved.

Authors:  Iñaki Comas; Jaidip Chakravartti; Peter M Small; James Galagan; Stefan Niemann; Kristin Kremer; Joel D Ernst; Sebastien Gagneux
Journal:  Nat Genet       Date:  2010-05-23       Impact factor: 38.330

Review 3.  Early Insights into Immune Responses during COVID-19.

Authors:  Ashley L St John; Abhay P S Rathore
Journal:  J Immunol       Date:  2020-06-08       Impact factor: 5.422

4.  The immune gene repertoire of an important viral reservoir, the Australian black flying fox.

Authors:  Anthony T Papenfuss; Michelle L Baker; Zhi-Ping Feng; Mary Tachedjian; Gary Crameri; Chris Cowled; Justin Ng; Vijaya Janardhana; Hume E Field; Lin-Fa Wang
Journal:  BMC Genomics       Date:  2012-06-20       Impact factor: 3.969

5.  A pneumonia outbreak associated with a new coronavirus of probable bat origin.

Authors:  Peng Zhou; Xing-Lou Yang; Xian-Guang Wang; Ben Hu; Lei Zhang; Wei Zhang; Hao-Rui Si; Yan Zhu; Bei Li; Chao-Lin Huang; Hui-Dong Chen; Jing Chen; Yun Luo; Hua Guo; Ren-Di Jiang; Mei-Qin Liu; Ying Chen; Xu-Rui Shen; Xi Wang; Xiao-Shuang Zheng; Kai Zhao; Quan-Jiao Chen; Fei Deng; Lin-Lin Liu; Bing Yan; Fa-Xian Zhan; Yan-Yi Wang; Geng-Fu Xiao; Zheng-Li Shi
Journal:  Nature       Date:  2020-02-03       Impact factor: 69.504

6.  Antibodies to coronaviruses are higher in older compared with younger adults and binding antibodies are more sensitive than neutralizing antibodies in identifying coronavirus-associated illnesses.

Authors:  Geoffrey J Gorse; Mary M Donovan; Gira B Patel
Journal:  J Med Virol       Date:  2020-03-03       Impact factor: 2.327

7.  Peptide presentation by bat MHC class I provides new insight into the antiviral immunity of bats.

Authors:  Dan Lu; Kefang Liu; Di Zhang; Can Yue; Qiong Lu; Hao Cheng; Liang Wang; Yan Chai; Jianxun Qi; Lin-Fa Wang; George F Gao; William J Liu
Journal:  PLoS Biol       Date:  2019-09-09       Impact factor: 8.029

8.  Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019.

Authors:  Juanjuan Zhao; Quan Yuan; Haiyan Wang; Wei Liu; Xuejiao Liao; Yingying Su; Xin Wang; Jing Yuan; Tingdong Li; Jinxiu Li; Shen Qian; Congming Hong; Fuxiang Wang; Yingxia Liu; Zhaoqin Wang; Qing He; Zhiyong Li; Bin He; Tianying Zhang; Yang Fu; Shengxiang Ge; Lei Liu; Jun Zhang; Ningshao Xia; Zheng Zhang
Journal:  Clin Infect Dis       Date:  2020-11-19       Impact factor: 9.079

Review 9.  COVID-19, SARS and MERS: are they closely related?

Authors:  N Petrosillo; G Viceconte; O Ergonul; G Ippolito; E Petersen
Journal:  Clin Microbiol Infect       Date:  2020-03-28       Impact factor: 8.067

10.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.

Authors:  Zunyou Wu; Jennifer M McGoogan
Journal:  JAMA       Date:  2020-04-07       Impact factor: 56.272

View more
  15 in total

1.  COVID-19 due to the B.1.617.2 (Delta) variant compared to B.1.1.7 (Alpha) variant of SARS-CoV-2: a prospective observational cohort study.

Authors:  Sebastien Ourselin; Emma L Duncan; Kerstin Kläser; Erika Molteni; Mark Graham; Liane S Canas; Marc F Österdahl; Michela Antonelli; Liyuan Chen; Jie Deng; Benjamin Murray; Eric Kerfoot; Jonathan Wolf; Anna May; Ben Fox; Joan Capdevila; Marc Modat; Alexander Hammers; Tim D Spector; Claire J Steves; Carole H Sudre
Journal:  Sci Rep       Date:  2022-06-28       Impact factor: 4.996

Review 2.  Complexity of Viral Epitope Surfaces as Evasive Targets for Vaccines and Therapeutic Antibodies.

Authors:  Nathaniel L Miller; Rahul Raman; Thomas Clark; Ram Sasisekharan
Journal:  Front Immunol       Date:  2022-06-17       Impact factor: 8.786

3.  Human herpesvirus diversity is altered in HLA class I binding peptides.

Authors:  William H Palmer; Marco Telford; Arcadi Navarro; Gabriel Santpere; Paul J Norman
Journal:  Proc Natl Acad Sci U S A       Date:  2022-04-29       Impact factor: 12.779

Review 4.  Characterization of SARS-CoV-2 different variants and related morbidity and mortality: a systematic review.

Authors:  SeyedAhmad SeyedAlinaghi; Pegah Mirzapour; Omid Dadras; Zahra Pashaei; Amirali Karimi; Mehrzad MohsseniPour; Mahdi Soleymanzadeh; Alireza Barzegary; Amir Masoud Afsahi; Farzin Vahedi; Ahmadreza Shamsabadi; Farzane Behnezhad; Solmaz Saeidi; Esmaeil Mehraeen
Journal:  Eur J Med Res       Date:  2021-06-08       Impact factor: 2.175

Review 5.  Current and prospective computational approaches and challenges for developing COVID-19 vaccines.

Authors:  Woochang Hwang; Winnie Lei; Nicholas M Katritsis; Méabh MacMahon; Kathryn Chapman; Namshik Han
Journal:  Adv Drug Deliv Rev       Date:  2021-02-06       Impact factor: 17.873

6.  How Cooperative Engagement Programs Strengthen Sequencing Capabilities for Biosurveillance and Outbreak Response.

Authors:  Andrew W Bartlow; Earl A Middlebrook; Alicia T Romero; Jeanne M Fair
Journal:  Front Public Health       Date:  2021-03-01

7.  The adaptation of SARS-CoV-2 to humans.

Authors:  Eduardo Tosta
Journal:  Mem Inst Oswaldo Cruz       Date:  2022-01-10       Impact factor: 2.743

8.  Performance of electrochemical immunoassays for clinical diagnostics of SARS-CoV-2 based on selective nucleocapsid N protein detection: Boron-doped diamond, gold and glassy carbon evaluation.

Authors:  Wioleta Białobrzeska; Mateusz Ficek; Bartłomiej Dec; Silvio Osella; Bartosz Trzaskowski; Andres Jaramillo-Botero; Mattia Pierpaoli; Michał Rycewicz; Yanina Dashkevich; Tomasz Łęga; Natalia Malinowska; Zofia Cebula; Daniel Bigus; Daniel Firganek; Ewelina Bięga; Karolina Dziąbowska; Mateusz Brodowski; Marcin Kowalski; Mirosława Panasiuk; Beata Gromadzka; Sabina Żołędowska; Dawid Nidzworski; Krzysztof Pyrć; William A Goddard; Robert Bogdanowicz
Journal:  Biosens Bioelectron       Date:  2022-04-08       Impact factor: 12.545

9.  Antigenic variation of SARS-CoV-2 in response to immune pressure.

Authors:  Diego Forni; Rachele Cagliani; Chiara Pontremoli; Alessandra Mozzi; Uberto Pozzoli; Mario Clerici; Manuela Sironi
Journal:  Mol Ecol       Date:  2020-12-02       Impact factor: 6.622

10.  Analysis of Genomic Characteristics of SARS-CoV-2 in Italy, 29 January to 27 March 2020.

Authors:  Alessandra Lo Presti; Angela Di Martino; Giovanni Faggioni; Francesco Giordani; Silvia Fillo; Anna Anselmo; Vanessa Vera Fain; Antonella Fortunato; Giancarlo Petralito; Filippo Molinari; Stefano Palomba; Riccardo De Santis; Stefano Fiore; Concetta Fabiani; Giuseppina Di Mario; Marzia Facchini; Laura Calzoletti; Florigio Lista; Giovanni Rezza; Paola Stefanelli
Journal:  Viruses       Date:  2022-02-25       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.